abacavir
12 May 2018. Related: ARVs, Nukes
ARVs
atazanavir
12 April 2016. Related: ARVs, PIs
Atripla / TLE (efavirenz + tenofovir DF + emtricitabine/lamivudine)
2 February 2025. Related: ARVs, Fixed dose combinations, NNRTIs, Nukes
Generic versions of Atripla (pictured) will look different. It is sometimes called TLE or AF2B.
Generic versions include Atenef, Atreslawin, Atroiza, Citenvir, Heftenam, Odimune, Rizene, Teevir, Trenvir, Tribuss, Triolar, Trivenz, Truno, Trustiva, Viraday and Vonavir.
Full details about Atripla / TLE (efavirenz + tenofovir DF + emtricitabine/lamivudine)
AZT (zidovudine)
1 April 2013. Related: ARVs, Nukes
bictegravir
1 January 2025. Related: ARVs, Integrase inhibitors
no separate formulation
Biktarvy: bictegravir/emtricitabine/TAF
30 August 2024. Related: ARVs, Fixed dose combinations, Integrase inhibitors, Nukes
Biktarvy is a pink/grey film-coated tablet (15 mm x 8 mm) with “GSI” on one side and “9883” on the other.
cabotegravir LA + rilpivirine LA (Vocabria+Rekambys or Cabenuva)
1 August 2024. Related: ARVs, Integrase inhibitors, NNRTIs
(not to scale)
Cabotegravir-LA and rilpivirine-LA are long acting injections given by intramuscular injections every two months.
Full details about cabotegravir LA + rilpivirine LA (Vocabria+Rekambys or Cabenuva)
cobicistat (Tybost)
12 April 2016. Related: ARVs, PK booster
Combivir (AZT + 3TC)
26 August 2012. Related: ARVs, Nukes
d4T (stavudine)
4 January 2016. Related: ARVs, Nukes
No longer recommended in the UK.
darunavir
30 June 2023. Related: ARVs, PIs
800 mg formulation shown
ddI (didanosine)
4 January 2016. Related: ARVs, Nukes
No longer recommended in the UK.
Descovy (TAF + emtricitabine)
12 May 2018. Related: ARVs, Nukes
10/200 mg (white) and 25/200 mg (blue)
dolutegravir
30 August 2024. Related: ARVs, Integrase inhibitors
Dolutegravir 50 mg is a 9 mm diameter round yellow tablet.
doravirine (Pifeltro)
18 November 2018. Related: ARVs, NNRTIs
Doravirine is a white tablet embossed with “700” on one side. (Source: aidsinfo.nih)
doravirine/TDF/3TC FDC (Delstrigo)
18 September 2019. Related: ARVs, Fixed dose combinations, NNRTIs, Nukes
Delstrigo is a light yellow tablet embossed with “776” on one side. (Source: aidsinfo.nih)
Dovato (dolutegravir + lamivudine)
30 August 2024. Related: ARVs, Fixed dose combinations, Integrase inhibitors, Nukes
Dovato is a white tablet embossed with “SV137”. (Source: aidsinfo.nih)
efavirenz
1 September 2016. Related: ARVs, NNRTIs
elvitegravir
1 May 2018. Related: ARVs, Integrase inhibitors
Single drug formulations of elvitegravir are no longer used. Instead, elvitegravir is included with other drugs in fixed dose combinations.
emtricitabine (FTC)
12 April 2016. Related: ARVs, Nukes
etravirine
14 May 2017. Related: ARVs, NNRTIs
(200 mg shown)
Eviplera (rilpivirine + tenofovir + FTC)
3 May 2013. Related: ARVs, Fixed dose combinations, NNRTIs, Nukes
Evotaz (atazanavir + cobicistat)
12 October 2016. Related: ARVs, PIs, PK booster
fosamprenavir
26 August 2012. Related: ARVs, PIs
fostemsavir (Rukobia)
1 February 2021. Related: ARVs, Entry inhibitors
Generic ARVs
30 August 2024. Related: ARVs, Fixed dose combinations, Integrase inhibitors, NNRTIs, Nukes, PIs
A generic drug is one that is manufactured by a different pharmaceutical company to the company that invented the medicine.
Genvoya: elvitegravir + cobicistat + emtricitabine + TAF (E/C/F/TAF)
12 April 2016. Related: ARVs, Fixed dose combinations, Integrase inhibitors, Nukes, PK booster
Full details about Genvoya: elvitegravir + cobicistat + emtricitabine + TAF (E/C/F/TAF)
Ibalizumab
22 March 2023. Related: ARVs, Entry inhibitors, monoclonal antibody (mAb)
Ibalizumab is a 200 mg concentrate that is then made up as an infusion.
indinavir
26 August 2012. Related: ARVs, PIs
No longer recommended in the UK.
Juluca (dolutegravir + rilpivirine)
12 May 2018. Related: ARVs, Fixed dose combinations, Integrase inhibitors, NNRTIs
Kaletra (lopinavir/r, Aluvia)
12 May 2018. Related: ARVs, PIs
No longer recommended in the UK.
Kivexa (abacavir + 3TC)
2 January 2018. Related: ARVs, Nukes
Lamivudine (3TC)
4 January 2022. Related: ARVs, Nukes
lenacapavir
28 August 2022. Related: ARVs, Capsid inhibitors, Experimental
(no pic available)
maraviroc
1 April 2013. Related: ARVs, CCR5 inhibitors, Entry inhibitors
nelfinavir
4 January 2022. Related: ARVs, PIs
No longer recommended in the UK. No longer manufactured.
nevirapine
1 April 2013. Related: ARVs, NNRTIs
Nevirapine 200 mg
Nevirapine-PR (prolonged release) 400 mg
Odefsey (rilpivirine + TAF + emtricitabine)
4 January 2022. Related: ARVs, Fixed dose combinations, NNRTIs, Nukes
Full details about Odefsey (rilpivirine + TAF + emtricitabine)
Prezcobix (darunavir + cobicistat) US name
12 April 2016. Related: ARVs, PIs, PK booster
Full details about Prezcobix (darunavir + cobicistat) US name
raltegravir
3 January 2022. Related: ARVs, Integrase inhibitors
Once-daily (600mg) Twice-daily (400 mg)
Rezolsta (darunavir plus cobicistat)
26 October 2016. Related: ARVs, PIs, PK booster
rilpivirine
12 May 2018. Related: ARVs, NNRTIs
ritonavir
1 April 2013. Related: ARVs, PIs, PK booster
New Meltrex tablet (non-refrigerated)
Old (original) capsule (requires refrigeration)
saquinavir
26 August 2012. Related: ARVs, PIs
Stribild (elvitegravir + cobicistat + emtricitabine (FTC) + tenofovir DF)
4 January 2022. Related: ARVs, Fixed dose combinations, Integrase inhibitors, Nukes
Full details about Stribild (elvitegravir + cobicistat + emtricitabine (FTC) + tenofovir DF)
Symtuza (darunavir + cobicistat + emtricitabine + TAF)
12 May 2018. Related: ARVs, Fixed dose combinations, Nukes, PIs
Full details about Symtuza (darunavir + cobicistat + emtricitabine + TAF)
T-20 (enfuvirtide)
26 August 2012. Related: ARVs, Entry inhibitors, Fusion inhibitors
tenofovir alafenamide (TAF)
12 February 2018. Related: ARVs, Nukes
No picture: TAF will only be available in coformulations with other HIV drugs.
tenofovir disoproxil (TD)
1 December 2020. Related: ARVs, Nukes
tipranavir
26 August 2012. Related: ARVs, PIs
TLD or LTD (tenofovir disoproxil, lamivudine, dolutegravir)
1 January 2025. Related: ARVs, Fixed dose combinations, Integrase inhibitors, NNRTIs
Picture not included as there are many different versions.
Full details about TLD or LTD (tenofovir disoproxil, lamivudine, dolutegravir)
TLE (tenofovir DF/lamivudine/efavirenz)
2 February 2025. Related: ARVs, Fixed dose combinations, NNRTIs, Nukes
Please see Atripla.
Triumeq (dolutegravir + abacavir + 3TC)
30 August 2024. Related: ARVs, Fixed dose combinations, Integrase inhibitors, Nukes
Trizivir (AZT + 3TC + abacavir)
26 August 2012. Related: ARVs, Fixed dose combinations, Nukes
Truvada (tenofovir-DF + FTC)
4 January 2022. Related: ARVs, Nukes
